A Phase II Trial of CPT-11 in Recurrent Squamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Author： Look K.Y. Blessing J.A. Levenback C. Kohler M. Chafe W. Roman L.D.

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.70, Iss.3, 1998-09, pp. : 334-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cisplatin and Pentoxifylline in Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group

By Mannel R.S. Blessing J.A. Boike G.

Gynecologic Oncology, Vol. 79, Iss. 1, 2000-10 ,pp. : 64-66

Elsevier

Access to resources Recommend Favorite

Phase II Evaluation of Altretamine for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Rose P.G. Blessing J.A. Arseneau J.

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 100-102

Academic Press

Access to resources Recommend Favorite

A Phase II Study of Topotecan in Patients with Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

By Muderspach L.I. Blessing J.A. Levenback C. Moore J.L.

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 213-215

Elsevier

Access to resources Recommend Favorite

Phase II Trial of 5-Fluorouracil and High-Dose Leucovorin in Recurrent Adenocarcinoma of the Cervix: A Gynecologic Oncology Group Study

By Look K.Y. Blessing J.A. Valea F.A. McGehee R. Manetta A. Webster K.D. Andersen W.A.

Gynecologic Oncology, Vol. 67, Iss. 3, 1997-12 ,pp. : 255-258

Elsevier

Access to resources Recommend Favorite

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study

By Fracasso P.M. Blessing J.A. Wolf J. Rocereto T.F. Berek J.S. Waggoner S.

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite